Sigma Healthcare Limited (FRA:S5YA)

Sigma Healthcare Statistics

Total Valuation

FRA:S5YA has a market cap or net worth of EUR 18.41 billion. The enterprise value is 19.49 billion.

Market Cap	18.41B
Enterprise Value	19.49B

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	Sep 2, 2025

Share Statistics

Current Share Class	11.50B
Shares Outstanding	n/a
Shares Change (YoY)	+830.43%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.04B

Valuation Ratios

The trailing PE ratio is 62.22 and the forward PE ratio is 44.09.

PE Ratio	62.22
Forward PE	44.09
PS Ratio	5.49
PB Ratio	7.07
P/TBV Ratio	40.71
P/FCF Ratio	60.36
P/OCF Ratio	55.06
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 40.43, with an EV/FCF ratio of 63.91.

EV / Earnings	65.89
EV / Sales	5.76
EV / EBITDA	40.43
EV / EBIT	43.26
EV / FCF	63.91

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.44.

Current Ratio	1.71
Quick Ratio	1.09
Debt / Equity	0.44
Debt / EBITDA	2.51
Debt / FCF	3.79
Interest Coverage	8.39

Financial Efficiency

Return on equity (ROE) is 19.54% and return on invested capital (ROIC) is 10.97%.

Return on Equity (ROE)	19.54%
Return on Assets (ROA)	8.62%
Return on Invested Capital (ROIC)	10.97%
Return on Capital Employed (ROCE)	11.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.08
Inventory Turnover	5.63

Taxes

In the past 12 months, FRA:S5YA has paid 121.72 million in taxes.

Income Tax	121.72M
Effective Tax Rate	29.33%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.66
200-Day Moving Average	1.65
Relative Strength Index (RSI)	38.14
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:S5YA had revenue of EUR 3.35 billion and earned 295.82 million in profits. Earnings per share was 0.03.

Revenue	3.35B
Gross Profit	804.04M
Operating Income	429.41M
Pretax Income	415.06M
Net Income	295.82M
EBITDA	445.48M
EBIT	429.41M
Earnings Per Share (EPS)	0.03

Balance Sheet

The company has 77.47 million in cash and 1.16 billion in debt, giving a net cash position of -1.08 billion.

Cash & Cash Equivalents	77.47M
Total Debt	1.16B
Net Cash	-1.08B
Net Cash Per Share	n/a
Equity (Book Value)	2.60B
Book Value Per Share	0.23
Working Capital	673.01M

Cash Flow

In the last 12 months, operating cash flow was 334.30 million and capital expenditures -29.34 million, giving a free cash flow of 304.95 million.

Operating Cash Flow	334.30M
Capital Expenditures	-29.34M
Free Cash Flow	304.95M
FCF Per Share	n/a

Margins

Gross margin is 24.00%, with operating and profit margins of 12.82% and 8.83%.

Gross Margin	24.00%
Operating Margin	12.82%
Pretax Margin	12.39%
Profit Margin	8.83%
EBITDA Margin	13.30%
EBIT Margin	12.82%
FCF Margin	9.10%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.46%.

Dividend Per Share	0.01
Dividend Yield	0.46%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	91.72%
Buyback Yield	-830.43%
Shareholder Yield	-829.97%
Earnings Yield	1.61%
FCF Yield	1.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:S5YA has an Altman Z-Score of 6.75 and a Piotroski F-Score of 6.

Altman Z-Score	6.75
Piotroski F-Score	6